Copyright Reports & Markets. All rights reserved.

Global Cancer Tumor Profiling Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Cancer Tumor Profiling Market Status and Forecast (2017-2028)
      • 1.3.2 Global Cancer Tumor Profiling Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Cancer Tumor Profiling Supply by Company

    • 2.1 Global Cancer Tumor Profiling Sales Value by Company
    • 2.2 Cancer Tumor Profiling Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Cancer Tumor Profiling Market Status by Type

    • 3.1 Cancer Tumor Profiling Type Introduction
      • 3.1.1 Next-generation Sequencing (NGS)
      • 3.1.2 Polymerase Chain Reaction (PCR)
      • 3.1.3 Immunohistochemistry (IHC)
      • 3.1.4 In Situ Hybridization (ISH)
      • 3.1.5 Microarray
      • 3.1.6 Others
    • 3.2 Global Cancer Tumor Profiling Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Cancer Tumor Profiling Market Status by Application

    • 4.1 Cancer Tumor Profiling Segment by Application
      • 4.1.1 Personalized Medicine
      • 4.1.2 Diagnostics
      • 4.1.3 Biomarker Discovery
      • 4.1.4 Prognostics
      • 4.1.5 Research Applications
    • 4.2 Global Cancer Tumor Profiling Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Cancer Tumor Profiling Market Status by Region

    • 5.1 Global Cancer Tumor Profiling Market by Region
    • 5.2 North America Cancer Tumor Profiling Market Status
    • 5.3 Europe Cancer Tumor Profiling Market Status
    • 5.4 Asia Pacific Cancer Tumor Profiling Market Status
    • 5.5 Central & South America Cancer Tumor Profiling Market Status
    • 5.6 Middle East & Africa Cancer Tumor Profiling Market Status

    6 North America Cancer Tumor Profiling Market Status

    • 6.1 North America Cancer Tumor Profiling Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Cancer Tumor Profiling Market Status

    • 7.1 Europe Cancer Tumor Profiling Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Cancer Tumor Profiling Market Status

    • 8.1 Asia Pacific Cancer Tumor Profiling Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Cancer Tumor Profiling Market Status

    • 9.1 Central & South America Cancer Tumor Profiling Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Cancer Tumor Profiling Market Status

    • 10.1 Middle East & Africa Cancer Tumor Profiling Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Cancer Tumor Profiling Market Forecast by Type and by Application

    • 12.1 Global Cancer Tumor Profiling Sales Value Forecast (2023-2028)
    • 12.2 Global Cancer Tumor Profiling Forecast by Type
    • 12.3 Global Cancer Tumor Profiling Forecast by Application

    13 Global Cancer Tumor Profiling Market Forecast by Region/Country

    • 13.1 Global Cancer Tumor Profiling Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 V., Strand
      • 14.1.1 Company Information
      • 14.1.2 Cancer Tumor Profiling Product Introduction
      • 14.1.3 V., Strand Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Siemens Healthineers
      • 14.2.1 Company Information
      • 14.2.2 Cancer Tumor Profiling Product Introduction
      • 14.2.3 Siemens Healthineers Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Roche Molecular Systems Inc.
      • 14.3.1 Company Information
      • 14.3.2 Cancer Tumor Profiling Product Introduction
      • 14.3.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Qiagen N.V.
      • 14.4.1 Company Information
      • 14.4.2 Cancer Tumor Profiling Product Introduction
      • 14.4.3 Qiagen N.V. Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Perthera, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Cancer Tumor Profiling Product Introduction
      • 14.5.3 Perthera, Inc. Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Personal Genome Diagnostics, Inc.
      • 14.6.1 Company Information
      • 14.6.2 Cancer Tumor Profiling Product Introduction
      • 14.6.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 NeoGenomics Laboratories
      • 14.7.1 Company Information
      • 14.7.2 Cancer Tumor Profiling Product Introduction
      • 14.7.3 NeoGenomics Laboratories Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Illumina Inc.
      • 14.8.1 Company Information
      • 14.8.2 Cancer Tumor Profiling Product Introduction
      • 14.8.3 Illumina Inc. Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 HTG Molecular Diagnostic
      • 14.9.1 Company Information
      • 14.9.2 Cancer Tumor Profiling Product Introduction
      • 14.9.3 HTG Molecular Diagnostic Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Hologic Gen-Probe
      • 14.10.1 Company Information
      • 14.10.2 Cancer Tumor Profiling Product Introduction
      • 14.10.3 Hologic Gen-Probe Cancer Tumor Profiling Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 GenScript
    • 14.12 Genomic Health Inc.
    • 14.13 Foundation Medicine, Inc
    • 14.14 Contextual Genomics
    • 14.15 Claris Life Sciences
    • 14.16 BD Biosciences
    • 14.17 ApoCell
    • 14.18 Agendia
    • 14.19 Abott Molecular

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Cancer Tumor Profiling market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Cancer Tumor Profiling industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Cancer Tumor Profiling market is estimated at $ 43100 million in 2021, and projected to grow at a CAGR of 11.9% to $ 94800 million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Cancer Tumor Profiling Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Cancer Tumor Profiling market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Cancer Tumor Profiling Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Cancer Tumor Profiling industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Next-generation Sequencing (NGS)
      Polymerase Chain Reaction (PCR)
      Immunohistochemistry (IHC)
      In Situ Hybridization (ISH)
      Microarray
      Others

      Segmented by Application
      Personalized Medicine
      Diagnostics
      Biomarker Discovery
      Prognostics
      Research Applications

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      V., Strand
      Siemens Healthineers
      Roche Molecular Systems Inc.
      Qiagen N.V.
      Perthera, Inc.
      Personal Genome Diagnostics, Inc.
      NeoGenomics Laboratories
      Illumina Inc.
      HTG Molecular Diagnostic
      Hologic Gen-Probe
      GenScript
      Genomic Health Inc.
      Foundation Medicine, Inc
      Contextual Genomics
      Claris Life Sciences
      BD Biosciences
      ApoCell
      Agendia
      Abott Molecular
      Buy now